Navigation Links
CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
Date:5/15/2008

BOSTON, May 15 /PRNewswire/ -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds that investigative sites are required to learn multiple EDC (electronic data capture) systems. More than 75% of respondents to a recent CenterWatch survey indicated that they had been trained on three or more EDC systems. In addition, a majority indicated that the effectiveness of their EDC training had improved.

State of the Clinical Trials Industry 2008 is a comprehensive resource that examines all aspects of the clinical trials industry based on proprietary research conducted by CenterWatch and resulting from analyses of industry surveys, physician and patient surveys; and surveys of investigative sites both in the U.S. and overseas. Data and research are presented on the following topics:

-- Site perception of sponsors and CROs globally

-- EDC uptake and usage

-- Patient experience in clinical trials

-- Major causes of trial delays and costs

-- Investigator concerns about trial conduct

-- Industry data on sales and market size

-- Worldwide regulatory submissions and approvals

"Each year researchers, biotech and pharmaceutical executives, CRO executives and investment analysts anticipate the release of the new edition of State of Clinical Trial Industry. It is a key resource that helps them track changes and understand key trends with analysis and insight into the global challenges in the industry," said Mary Jo Lamberti, PhD, Director of Market Research for CenterWatch.

State of the Clinical Trials Industry 2008 contains over 600 charts, graphs, and tables, a review of the top clinical research stories of 2007 as reported by the editorial staff of the CenterWatch newsletters; as well as drug pipeline information and updates on specific disease areas. Much of the data is based on CenterWatch's proprietary clinical research benchmarking surveys that represent global analysis of current sponsor and CRO practices. The 2008 edition features more than 90 completely new charts analyzing the clinical research industry along with updates for hundreds of charts and tables that have become a requirement for industry executives, market researchers, and analysts.

To purchase your copy of State of the Clinical Trials Industry 2008 at the introductory rate of $549 (+ s/h), regular $699 (Special offer of $549 through May 30). Call us at 800-765-9647 or visit our online bookstore at http://www.centerwatch.com.

Corporate licenses are available. For more information, contact us at sales@centerwatch.com or 866-219-3440, ext. 4.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for professionals and patients. A Boston-based publishing and information services company focusing on the clinical research industry, CenterWatch is a business of Jobson Medical Information, LLC. CenterWatch provides proprietary data and information about clinical trials through a variety of publications, databases and information services used by pharmaceutical and biotech companies, CROs, SMOs and investigative sites involved in all aspects of clinical trials.

As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish information about active clinical trials that could be accessed by patients and their advocates. Today, CenterWatch has one of the largest databases of clinical trials actively recruiting patients on the Internet. For more information about CenterWatch's publications and services, please visit http://www.centerwatch.com.


'/>"/>
SOURCE CenterWatch
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
2. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
3. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
4. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
6. Immunosyn Corporation Releases SF-1019 Study Results
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
9. CEL-SCI Corporation Releases Letter to Shareholders
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... its fiscal 2016 first quarter ended December 31, 2015. ... Fiscal 2016 First Quarter Highlights , Revenue of ... quarter of 2015 , Domestic Radiation Measurement services revenues ...
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... Feb. 9, 2016 Mast Therapeutics, Inc. ... for sickle cell disease and heart failure, today announced that ... to purchase common stock in an underwritten public offering.  The ... can be no assurance as to whether or when the ... or terms of the offering.   --> ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... ... The Journal of Pain Research has published the commentary “ Terminology of ... Dr John F. Peppin says “Terminology matters, yet little attention has been paid to ... cancer pain’ and ‘chronic non-cancer pain’ are replete in the literature; however, the distinction ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... The guide will ensure lab personnel have a basic understanding of the techniques ... measurement protocols. Enhanced understanding will help them reduce waste and rework to create ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... cleaning and sealing company , is proud to announce that many of their ... levels of customer service. The hard surface restoration franchises received customer recognition through ...
(Date:2/8/2016)... PLAINSBORO, N.J. (PRWEB) , ... February 08, 2016 , ... ... on cancer patients, has officially launched the Multiple Myeloma Heroes Awards event , ... (MM) or in the lives of patients with MM. The MM Heroes Awards ...
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie ... celebrates the beginning of a new charity campaign. As part of their ongoing ... Advocates (CASA). In the belief that children deserve a voice, and in the ...
Breaking Medicine News(10 mins):